Top Markets
#1 Black Phoenix Black Phoenix +367.84%
#2 Islamic Coin Islamic Coin +158.32%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +54.93%
#5 Akedo Akedo +49.03%
#6 Acurast Acurast +38.06%
#7 BasedHype BasedHype +30.19%
#8 Cryptopia Cryptopia +22.04%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.18%
#10 Playnance Playnance +19.72%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Genomic Vision S.A. Genomic Vision S.A.

Genomic Vision S.A.

GV
Classement en actions #41548
Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A.... Headquartered in Bagneux, France, and established in 2004, Genomic Vision S.A. is a molecular diagnostics and technology company focused on developing sophisticated tools for analyzing individual DNA molecules. These innovations serve both scientific research and in vitro diagnostic purposes. A cornerstone of their offerings is the FiberVision molecular combing platform, which streamlines DNA analysis workflows. This platform integrates FiberComb, a system for stretching single DNA molecules onto vinyl silane glass, with a FiberVision scanner designed to acquire high-resolution images of entire coverslip surfaces automatically. The data is then processed by FiberStudio software, which detects hybridization signals, analyzes results, and generates reports. Supporting these systems, the company provides the FiberPrep DNA extraction kit, producing purified DNA for combing, alongside essential accessories such as custom-treated glass carriers and disposable DNA reservoirs. Genomic Vision also offers specialized FiberProbes, including "Genomic Morse Code" sets for detecting mutations associated with hereditary breast and ovarian cancer (BRCA), as well as for identifying and characterizing structural variations related to hereditary nonpolyposis colorectal cancer, particularly anomalies in the flanking regions of MMR genes. Additionally, their molecular combing services enable clients to validate planned gene editing events, identify substantial unintended modifications (exceeding 1 kilobase), and precisely quantify on-target versus off-target genetic changes. The company reinforces its position through strategic partnerships, including an alliance with Quest Diagnostics and development and research collaborations with La Timone Hospital and the Institut Pasteur, respectively.
Prix de l'action
$0.00196068
Dernière synchronisation: 2023-12-01
Capitalisation boursière
$16.64K
Changement (1 jour)
0.01%
Changement (1 an)
0.00%
Pays
FR
Échange Genomic Vision S.A. (GV)

Catégorie

Healthcare
Le prix GV avec la capitalisation boursière de B
Genomic Vision S.A. Genomic Vision S.A.
GV
$0.00196068
Capitalisation boursière de Genomic Vision S.A.(GV)
Capitalisation boursière: $16.64K
En August 2026, Genomic Vision S.A. a une capitalisation boursière de $16.64K. Cela fait de Genomic Vision S.A. la 41548th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Genomic Vision S.A. du 2014 au 2026
GV par rapport au top 5 des plus populaires stocks
Prix pour GV L’actif B La capitalisation boursière de B Résultats
Genomic Vision S.A. Genomic Vision S.A.
$641,904 $16.64K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.448T +32,738,882,267.17%
Genomic Vision S.A. Genomic Vision S.A.
$526,242 $16.64K
Apple Inc. Apple Inc.
AAPL
$4.466T +26,839,796,415.25%
Genomic Vision S.A. Genomic Vision S.A.
$490,214 $16.64K
Alphabet Inc. Alphabet Inc.
GOOG
$4.160T +25,002,282,125.49%
Genomic Vision S.A. Genomic Vision S.A.
$436,709 $16.64K
Microsoft Corporation Microsoft Corporation
MSFT
$3.706T +22,273,358,529.05%
Genomic Vision S.A. Genomic Vision S.A.
$340,578 $16.64K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.890T +17,370,432,411.43%